RGEN Historical PE Ratio image   This RGEN PE ratio history page last updated 11/3/2022
RGEN PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2022
11/1/2022
185.550.773.4154.4
Q2 2022
8/2/2022
237.380.913.4269.4
Q1 2022
4/27/2022
157.510.923.3047.7
Q4 2021
2/17/2022
182.420.813.0659.6
Q3 2021
10/28/2021
290.020.782.77104.7
Q2 2021
7/27/2021
226.380.792.3994.7
Q1 2021
5/4/2021
194.670.682.0296.4
Q4 2020
2/24/2021
215.580.521.66129.9
Q3 2020
11/5/2020
201.860.401.34150.6
Q2 2020
7/30/2020
151.250.421.20126.0
Q1 2020
5/6/2020
124.710.321.09114.4
Q4 2019
2/20/2020
101.120.201.0596.3
Q3 2019
10/31/2019
79.490.261.0675.0
Q2 2019
8/1/2019
95.510.311.0095.5
Q1 2019
5/9/2019
69.860.280.8582.2
Q4 2018
2/21/2019
58.050.210.7478.4
Q3 2018
11/1/2018
63.550.200.7387.1
Q2 2018
8/2/2018
47.280.160.6869.5
Q1 2018
5/8/2018
40.520.170.7256.3
Q4 2017
2/22/2018
34.980.200.7050.0
Q3 2017
11/9/2017
36.180.150.5862.4
Q2 2017
8/3/2017
41.440.200.5181.3
Q1 2017
5/4/2017
38.010.150.4780.9
Q4 2016
2/22/2017
32.320.080.4473.5
Q3 2016
11/3/2016
26.640.080.4362.0
Q2 2016
8/4/2016
29.950.160.4369.7
Q1 2016
5/5/2016
25.920.120.3868.2
Q4 2015
2/25/2016
25.780.070.3769.7
Q3 2015
11/5/2015
32.380.080.29111.7
Q2 2015
8/6/2015
36.000.110.25144.0
Q1 2015
5/7/2015
37.550.110.23163.3
Q4 2014
3/13/2015
31.31-0.010.25125.2
Q3 2014
11/6/2014
23.350.040.3664.9
Q2 2014
8/11/2014
22.340.090.5044.7
Q1 2014
5/8/2014
17.290.130.5531.4
Q4 2013
3/6/2014
14.170.100.4928.9
Q3 2013
11/7/2013
11.510.180.09127.9
Q2 2013
8/1/2013
10.230.14NANA
Q1 2013
5/2/2013
8.800.07NANA
Q4 2012
3/7/2013
6.72-0.30NANA
RGEN Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2022
11/1/2022
185.550.773.0860.2
Q2 2022
8/2/2022
237.380.913.6465.2
Q1 2022
4/27/2022
157.510.923.6842.8
Q4 2021
2/17/2022
182.420.813.2456.3
Q3 2021
10/28/2021
290.020.783.1293.0
Q2 2021
7/27/2021
226.380.793.1671.6
Q1 2021
5/4/2021
194.670.682.7271.6
Q4 2020
2/24/2021
215.580.522.08103.6
Q3 2020
11/5/2020
201.860.401.60126.2
Q2 2020
7/30/2020
151.250.421.6890.0
Q1 2020
5/6/2020
124.710.321.2897.4
Q4 2019
2/20/2020
101.120.200.80126.4
Q3 2019
10/31/2019
79.490.261.0476.4
Q2 2019
8/1/2019
95.510.311.2477.0
Q1 2019
5/9/2019
69.860.281.1262.4
Q4 2018
2/21/2019
58.050.210.8469.1
Q3 2018
11/1/2018
63.550.200.8079.4
Q2 2018
8/2/2018
47.280.160.6473.9
Q1 2018
5/8/2018
40.520.170.6859.6
Q4 2017
2/22/2018
34.980.200.8043.7
Q3 2017
11/9/2017
36.180.150.6060.3
Q2 2017
8/3/2017
41.440.200.8051.8
Q1 2017
5/4/2017
38.010.150.6063.4
Q4 2016
2/22/2017
32.320.080.32101.0
Q3 2016
11/3/2016
26.640.080.3283.2
Q2 2016
8/4/2016
29.950.160.6446.8
Q1 2016
5/5/2016
25.920.120.4854.0
Q4 2015
2/25/2016
25.780.070.2892.1
Q3 2015
11/5/2015
32.380.080.32101.2
Q2 2015
8/6/2015
36.000.110.4481.8
Q1 2015
5/7/2015
37.550.110.4485.3
Q4 2014
3/13/2015
31.31-0.01-0.04NA
Q3 2014
11/6/2014
23.350.040.16145.9
Q2 2014
8/11/2014
22.340.090.3662.1
Q1 2014
5/8/2014
17.290.130.5233.2
Q4 2013
3/6/2014
14.170.100.4035.4
Q3 2013
11/7/2013
11.510.180.7216.0
Q2 2013
8/1/2013
10.230.140.5618.3
Q1 2013
5/2/2013
8.800.070.2831.4
Q4 2012
3/7/2013
6.72-0.30-1.20NA
Quotes delayed 20 minutes

Email EnvelopeFree RGEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Repligen (RGEN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RGLS PE Ratio History
RGNX PE Ratio History
RIGL PE Ratio History
RLAY PE Ratio History
RLMD PE Ratio History
RLYB PE Ratio History
RMD PE Ratio History
RMED PE Ratio History
RMTI PE Ratio History
RNA PE Ratio History
On this page we presented the RGEN PE Ratio History information for Repligen' stock. The average RGEN PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 71.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RGEN PE ratio history based on this TTM earnings result method is 85.1. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RGEN PE ratio history result, against the recent PE: when this page was posted on 11/2/2022, the most recent closing price for RGEN had been 171.52, and the most recent quarterly earnings result, annualized, was 3.08. Meanwhile, the most recent TTM earnings summed to 3.41. From these numbers, we calculate the recent RGEN PE on 11/2/2022 based on annualized quarterly EPS was 55.7. Based on RGEN's history, that recent PE is low relative to the historical average, with the recent PE 21.9% lower than the historical average PE across our data set for Repligen. Looking at the recent RGEN PE on 11/2/2022 based on TTM EPS, we calculate the ratio at 50.3. Based on RGEN's history, that recent PE is low relative to the historical average, with the recent PE 40.9% lower than the average PE across our Repligen data set with TTM EPS used in the calculation at each period.

Another interesting RGEN PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for RGEN, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for RGEN, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.77, 0.81, 0.91, and 0.92. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.81 and 0.91 — which gives us the median of 0.86. Basically the way to think about this 0.86 number is this: for the trailing four earnings reports, 0.86 marks the "middle ground" number where RGEN has reported a value higher than 0.86 half the time, and has reported a value lower than 0.86 half the time. Annualizing that median value then gets us to 3.44/share, which we use as the denominator in our next PE calculation. With 171.52 as the numerator (as of 11/2/2022), the calculation is then 171.52 / 3.44 = 49.9 as the RGEN PE ratio as of 11/2/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on RGEN or any other given stock, valuation analysis for RGEN can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Repligen PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for RGEN. Thanks for visiting, and the next time you need to research RGEN PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: ESRX Price Target, Funds Holding SUZ, VOLC Videos.

 

RGEN PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.